Therapies for Heart Failure: Clinical Updates and Perspectives
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: 20 June 2026 | Viewed by 465
Special Issue Editors
2. County Emergency Hospital "Pius Brinzeu", L. Rebreanu, Nr. 156, 300723 Timisoara, Romania
3. Center of Molecular Research in Nephrology and Vascular Disease, Faculty of the University of Medicine and Pharmacy "Victor Babes" Timisoara, E. Murgu Square, Nr. 2, 300041 Timisoara, Romania
Interests: heart failure; systemic hypertension; acute and chronic coronary syndrome; arrhythmias; management of patients with cardiovascular diseases; cardiovascular risk factors
Interests: rehabilitation in heart failure; risk prediction in cardiovascular disease; heart failure in patients with cancer; cardiovascular disease and autoimmune disease
2. Research Center of the Institute of Cardiovascular Diseases Timisoara, 13A Gheorghe Adam Street, 300310 Timisoara, Romania
Interests: echocardiography; left-atrial function; device implantation; complex arrhythmia ablation; heart failure
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Although the symptoms of heart failure (HF) have been recognized for decades, there is still disagreement among researchers regarding its clinical presentation and optimal therapeutic strategies. As societies evolve, the signs and symptoms of HF are also adapting, showing considerable variation across populations depending on race, ethnicity, cultural background, lifestyle, and the presence of comorbidities such as cancer or diabetes mellitus.
Clinical manifestations, along with associated comorbidities, significantly influence the progression of HF, compelling clinicians to tailor treatment plans and explore novel therapeutic avenues.
A recent breakthrough in HF management has been the development of new oral glucose-lowering agents, particularly sodium–glucose cotransporter-2 inhibitors (SGLT2i). This drug class has become a cornerstone of HF therapy, with ongoing research continually revealing additional benefits. At every major cardiology conference, innovative diagnostic techniques, clinical strategies for symptom relief, and a spectrum of treatment options—from new pharmacological agents to minimally invasive device implants and advanced cardiac surgery—are being presented and discussed.
This Special Issue will be dedicated to advancing our understanding of the etiology and management of HF. We welcome the submission of original research articles and reviews that align with this aim.
Dr. Cristina Tudoran
Dr. Stela Iurciuc
Prof. Dr. Dragos Cozma
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mechanisms of heart failure
- new therapies for heart failure
- chronic and acute heart failure
- new approaches to managing heart failure patients
- special populations
- clinical outcome
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
